Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting HER2 in metastatic gastroesophageal adenocarcinomas: What is new?
Coutzac C, Funk-Debleds P, Cattey-Javouhey A, Desseigne F, Guibert P, Marolleau P, Rochefort P, de la Fouchardière C. Coutzac C, et al. Among authors: desseigne f. Bull Cancer. 2023 May;110(5):552-559. doi: 10.1016/j.bulcan.2022.08.013. Epub 2022 Oct 10. Bull Cancer. 2023. PMID: 36229267 Free article. Review.
[Cardiac metastases and colorectal cancer: a case study].
de la Fouchardière C, Desseigne F, Orlandini F, de la Fouchardière A, Négrier S. de la Fouchardière C, et al. Among authors: desseigne f. Gastroenterol Clin Biol. 2007 Jun-Jul;31(6-7):621-3. doi: 10.1016/s0399-8320(07)89443-7. Gastroenterol Clin Biol. 2007. PMID: 17646793 Free article. Review. French.
Phase I study of daily irinotecan as a radiation sensitizer for locally advanced pancreatic cancer.
de la Fouchardière C, Négrier S, Labrosse H, Martel Lafay I, Desseigne F, Méeus P, Tavan D, Petit-Laurent F, Rivoire M, Pérol D, Carrie C. de la Fouchardière C, et al. Among authors: desseigne f. Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):409-13. doi: 10.1016/j.ijrobp.2009.05.008. Epub 2010 Jan 29. Int J Radiat Oncol Biol Phys. 2010. PMID: 20116933 Clinical Trial.
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardière C, Bennouna J, Bachet JB, Khemissa-Akouz F, Péré-Vergé D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux M; Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup. Conroy T, et al. Among authors: desseigne f. N Engl J Med. 2011 May 12;364(19):1817-25. doi: 10.1056/NEJMoa1011923. N Engl J Med. 2011. PMID: 21561347 Free article. Clinical Trial.
An unusual presentation of pancreatic cancer: Muscular metastasis.
Belbarka R, Fadoukheir Z, Delafouchardiere C, Desseigne F, Errihani H. Belbarka R, et al. Among authors: desseigne f. Indian J Cancer. 2014 July-September;51(3):369-370. doi: 10.4103/0019-509X.146714. Indian J Cancer. 2014. PMID: 25494141 Free article. No abstract available.
The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value.
Jiang X, Pissaloux D, De La Fouchardiere C, Desseigne F, Wang Q, Attignon V, Fondrevelle ME, De La Fouchardiere A, Perol M, Cassier P, Seigne C, Perol D, Ray-Coquard I, Meeus P, Fayette J, Flechon A, Le Cesne A, Penel N, Tredan O, Blay JY. Jiang X, et al. Among authors: desseigne f. Oncotarget. 2015 Sep 22;6(28):26388-99. doi: 10.18632/oncotarget.4557. Oncotarget. 2015. PMID: 26317543 Free PMC article.
70 results